Medtronic wins Japanese approval for MRI-safe pacemaker; Brazilian regulators gives companies extension;

@FierceMedDev: ICYMI: Power morcellation ban unlikely, but other FDA restrictions coming soon; includes email to FDA obtained by FMD. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDrugDelivery: The new AstraZeneca, University of Manchester center for drug delivery becomes operational in February. More | Follow @VarunSaxena2

> Medtronic ($MDT) wins Japanese approval of the Evera MRI SureScan system implantable cardioverter-defibrillator system enabling MRI scans in patients with the device. Release

> Brazil's med tech regulator, ANVISA, is giving companies automatic extensions to comply with its new rules. More

Biotech News

@FierceBiotech: Biotech upstart Sage sees early efficacy for rare brain seizure drug. More | Follow @FierceBiotech

@JohnCFierce: From FierceBiotechResearch: Genentech R&D team fixes a flawed approach to Alzheimer's. Story | Follow @JohnCFierce

> Battered ArQule shares bump up on badly needed positive data for tivantinib. Article

> Fledgling Ziarco grabs a $33M transatlantic round for PhII atopic dermatitis drug. Story

> J&J chief hints at unease in China, but plots new buyouts. Item

> Merck's hepatitis C cocktail drug fails a 4-week challenge. Report

Pharma News

@FiercePharma: FDA tightens reins on equine compounding companies. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI Friday: Fresenius Russian partnership tanks even as Russian tanks spotted rolling into Ukraine. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Eisai 'speechless' after another Fycompa price smack-down from Germany. More | Follow @CarlyHFierce

> J&J eyes dealmaking in China to ratchet up pharma sales. Article

> For sale: Bankrupt Dendreon and its laggard Provenge, for $275M or more. Any takers? More

CRO News

> India's GVK snags an early-stage CRO amid global growth. News

> Charles River deepens its ties to Huntington's R&D with new deal. Item

> FDA taps Icon to help patients better weigh in on trials. Story

> PPD dives into adaptive trials with Medidata deal. Report

> AMRI tanks on disappointing sales and a dimmer outlook. Article

Biotech IT News

> Google steps up Genomics pitch with $25-a-genome storage service. More

> Team taps Wikipedia for flu forecasting data. Story

> Open-source atlas of the human proteome goes live. Article

> FDA resumes its long search for a CIO. More

> AstraZeneca strikes $150M deal to buy data analysis business. Report

Animal Health News

> Jaguar postpones IPO amid rocky market for biotech and animal health offerings. Article

> Merck to meat industry: Zilmax is safe. Item

> FDA tightens reins on equine compounding companies. Report

> MWI shares sink despite better-than-expected earnings. Story

> Zoetis beats estimates on strength of livestock products and allergy drug for dogs. News

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.